1. Medtech Insight
  2. >>Geography
  3. >>Europe
  4. >>Germany

Podcast: German Hospital Reform Ushers In A Reimbursement ‘Revolution’

Market access expert explains significance for medtech industry

 
• By Ashley Yeo

Germany is introducing a new system of paying for inpatient care, whereby funds will be allocated both to diagnosis related groups and to a provisional pot from which funds will be distributed according to the type of care delivered. In this podcast with Medtech Insight, Gabriel Flemming of Germany Trade & Invest explains what it all means for medtech.

Shutterstock

When Karl Lauterbach was appointed health minister in Germany’s “traffic light” coalition government of the center-left SPD, Liberal FDP and Green Party, he vowed to overhaul the country‘s costly system of inpatient care. Patients were prone to being overtreated and spending too long in the inpatient setting, he said.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Germany

Medtechs Eye German Health Minister Switch As Governing Parties Reach Coalition Agreement

 
• By Ashley Yeo

The architect of Germany’s hospital reform, Karl Lauterbach, will not be retained as health minister according to how the new CDU/CSU-SPD coalition government plans to spread the ministerial portfolios.

Get A Grip On Healthcare And Tariffs German Medtechs Tell Incoming Coalition

 
• By Ashley Yeo

The IVD industry’s new 10-point plan for healthcare change shows that medtechs will keep calling the German government to account. Tariffs, sector resilience, digital functionality are among the pressing issues industry wants answers to.

German Medtechs Up The Stakes On Amending Hospital Reform Law

 
• By Ashley Yeo

Whoever is handed the health portfolio in Germany’s new coalition government will face demands to amend the recently-enacted hospital and DRGs reform law. The medtech industry has been quick to make the case for change.

New German Coalition Expected To Prioritize Prevention And Healthcare Deregulation

 
• By Ashley Yeo

Germany’s Union parties may have little alternative than to bring the SPD into a new four-year coalition, says Clifford Chance partner and life sciences legal expert Gunnar Sachs. Health policy will likely see both textural and structural changes.

More from Europe

US Medtech Tariffs: How Will EU Navigate Unchartered Territory?

 
• By Amanda Maxwell

US President Trump has imposed sweeping tariffs that encompass medtech. These are expected to drive up costs, disrupt supply chains and hinder innovation, likely driving the EU to seek new trade partnerships to mitigate the impact.

UK Treading A Tightrope On Trump’s Tariffs

 
• By Ashley Yeo

Medtech has not yet been spared from the Trump administration’s trade tariffs, which, for UK exporters will be 10% – half the rate applied to EU27 exporters.

Swiss Blast US Import Tariffs As Medtechs Look For Dialog To Forestall Damage To Industry

 
• By Ashley Yeo

Swiss medtech exporters seek urgent diplomatic action from the Swiss Federal Council in a bid to overturn the 2 April US decision to put tariffs on goods imports.